Evolution Wealth Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-87
Closed -$19K 164
2021
Q3
$19K Hold
87
﹤0.01% 317
2021
Q2
$21K Hold
87
﹤0.01% 296
2021
Q1
$22K Hold
87
﹤0.01% 276
2020
Q4
$20K Hold
87
﹤0.01% 262
2020
Q3
$22K Hold
87
0.01% 261
2020
Q2
$21K Buy
+87
New +$19.9K 0.01% 198
2020
Q1
Sell
-76
Closed -$18K 321
2019
Q4
$18K Sell
76
-4
-5% -$882 ﹤0.01% 232
2019
Q3
$15K Buy
80
+8
+11% +$1.54K 0.01% 129
2019
Q2
$13K Buy
+72
New +$12.9K 0.01% 156

Other funds holding AMGN

Evolution Wealth Advisors's AMGN Position: Q4 2021 in Review

Evolution Wealth Advisors sold out of Amgen (AMGN) in Q4 2021, closing a stake of 87 shares — an estimated $19K sold.

Evolution Wealth Advisors first reported a position in AMGN in Q2 2019 and held it in 9 quarters. The position peaked at $22K in Q1 2021. 2,293 funds tracked by Wall St. Rank hold AMGN as of Q4 2021.

  • Evolution Wealth Advisors reported no remaining Amgen position as of Q4 2021 after selling out during the quarter.
  • Evolution Wealth Advisors sold 87 Amgen shares in Q4 2021, an estimated $19K.
  • Evolution Wealth Advisors first reported a position in Amgen in Q2 2019 and held it in 9 quarters.
  • Evolution Wealth Advisors's Amgen position peaked at $22K in Q1 2021.
  • 2,293 funds tracked by Wall St. Rank held Amgen as of Q4 2021.

Based on Evolution Wealth Advisors's 13F filing for Q4 2021, filed 28 Jan 2022.